Arcturus stockholders approve 2M share increase to equity incentive plan at annual meeting

Arcturus Therapeutics Holdings Inc.

Amendment to 2019 Omnibus Equity Incentive Plan approved: shares increased by 2,000,000 to 10,750,000 total.
All eight director nominees elected (e.g., Peter Farrell, Joseph Payne) to serve until 2025 annual meeting.
Say-on-pay approved with 19,875,930 For, 1,069,592 Against, 58,600 Abstain.
Ratification of Deloitte & Touche LLP as independent auditor for FY 2024 ratified (23,267,449 For).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.